万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>期刊大全 >>医卫科学>>儿科学

儿科学研究(英文)(Pediatric Investigation) (官网投稿)

简介
《儿科学研究(英文)》(Pediatric Investigation)(季刊),由中国科学技术协会主管,中华医学会主办。该刊希望可以更多服务于全球范围内儿科领域年轻学者,杂志不仅要分享转化医学研究,也要分享对儿童最佳护理的进展研究。
本刊为:CSCD核心(2019-2020), 外文期刊,
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、官网网址:

https://onlinelibrary.wiley.com/journal/25742272

投稿系统:

https://mc.manuscriptcentral.com/ped4

3、官网邮箱:pieditorial@pediatricinvestigation.org

4、官网电话:010-66019629

2019514日星期二

                            

 

《儿科学研究(英文)》作者指南

【官网信息】

 

Author Guidelines for Pediatric Investigation

1. Submission

2. Aims and Scope

3. Manuscript Categories and Requirements

4. Preparing Your Submission

5. Editorial Policies and Ethical Considerations

6. Open Access License and Copyright

7. Publication Process after Acceptance

8. Post Publication

9. Editorial Office Contact Details

1. SUBMISSION

Thank you for your interest in Pediatric Investigation. Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/ped4

The submission system will prompt you to use an ORCID iD (a unique author identifier) to help distinguish your work from that of other researchers. Click here to find out more.

Click here for more details on how to use ScholarOne.

For help with submissions, please contact: pieditorial@pediatricinvestigation.org

We look forward to your submission.

2. AIMS AND SCOPE

Pediatric Investigation serves to disseminate the cutting-edge knowledge on clinical observations of pediatric research. It focuses on clinical care, clinical practice and translational medicine in the field. The editors encourage contributions relating to pediatric internal medicine, surgery, radiology, pathology, biochemistry, physiology, sociology and history, preventive healthcare, pharmacology and many pediatric subspecialties.

Pediatric Investigation considers unsolicited manuscripts in the following categories: Original Article, Review Article, Commentary, Case Report, Brief Report. The editors will also invite manuscripts to publish in the special feature columns: Editorial, Guidelines, Consensus or Recommendations, Medical News, Lecture, Workshop, Journal Club, Characters in Pediatrics, and Clinical Experience.

Keywords: Pediatrics, Pediatric subspecialties, cutting-edge knowledge, Research, Guidelines

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

Editorial

Word limit: 1200 words maximum excluding references, tables and figures. Abstract: not required. References: 20 maximum, including the article discussed. Figures/tables: 1 maximum. Description: Editorials are usually solicited, however, unsolicited editorials are also welcome. Editorials usually discuss a paper published in the same or a specific issue of the journal for further understanding and research.

Original Article

Word limit: 4000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, with sub-headers: Importance, Objective, Methods, Results, Interpretation. The main text of Original Article should be structured using the following sections: Introduction, Methods, Results, Discussion. References: no limit. Figures/tables: figures plus tables should not exceed 8. Description: Full-length reports of current research in either clinical research or basic science with the latter having certain potential of clinical application.

Review Article

Word limit: 5000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, unstructured (no use of sub-headers). References: no limit. Figures/tables: minimum 1 image or figure. Description: Reviews are comprehensive analyses of specific topics. Proposals for reviews may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.

Commentary

Word limit: 1500 words maximum excluding references. Abstract: not required. References: 20 maximum, including the article discussed. Figures/tables: 2 maximum. Description: Commentaries, upon Editor’s invitation, discuss a paper published in a specific issue and should set the problems addressed by the paper in the wider context of the field. Proposals for Commentaries may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.

Case Report / Case Study

Word limit: 1500 words maximum excluding references, tables and figures. An abstract of about 100 words composed of Introduction, Case Presentation and Conclusion is needed. References: 20 maximum. Figures/tables: 4 maximum. Description: New observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in pediatric research. The text should be arranged as follows: Introduction, Case Report, and Discussion. Only cases of exceptional interest and novelty are considered.

Brief Report

Word limit: 2000 words including abstract but excluding references, tables and figures. Abstract: 150 words maximum, unstructured (no use of sub-headers). References: 35 maximum. Figures/tables: 4 maximum. Description: Manuscripts containing pertinent and interesting observations concerning pediatric research and reports on new observations or studies that do not warrant publication as a full research article will be considered for the Brief Reports. These submissions will undergo full peer review.

Guidelines, Consensus or Recommendations

Word limit: 5000 maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, unstructured (no use of sub-headers). References: no limit. Figures/tables: minimum 1 image or figure. Description: Guidelines, consensus or recommendations need to be the product of a large group of individuals who are recognized authorities in their field. They will be written by a working party to include a steering committee (usually at least 4 members) and other authors representing a wide range of those with special relevant expertise as well as those whose everyday practice will be influenced by the guidelines, consensus or recommendations.

Medical News

Word limit: 500 words maximum. Abstract: not required. References: 5 maximum. Figures: 2 maximum. Description: Proposals for Medical News may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.

Lecture/Workshop

Word limit: 5000, may or may not include abstract but excluding references, tables and figures. Abstract: 150 words, unstructured (no use of sub-headers). References: 35 maximum. Figures/tables: 4 maximum. Description: Manuscripts containing pertinent designs and methods concerning clinical and translational studies will be considered for the Lecture/Workshop.

Journal Club

Word limit:1000 words maximum excluding references. Abstract: not required. References: 20 maximum, including the article discussed. Figures/tables: 2 maximum. Description: Manuscripts discuss a high-quality paper published recently in other journals and should set the problems addressed by the paper in the wider context of the field. Proposals for Journal Club may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.

Notable Characters in Pediatrics

Word limit: 500 maximum. Abstract: not required. References: not required. Figures: 2 maximum. Description: Proposals for Notable Characters in Pediatrics may be submitted; however, in this case authors should only send an outline of the proposed article for initial consideration.

Clinical Experience

Word limit: Maximum 2000 words including abstract but excluding references, tables and figures. Abstract: 150 words, unstructured (no use of sub-headers). References: 35 maximum. Figures/tables: 4 maximum. Description: Manuscripts containing pertinent and interesting thoughts and practices concerning clinical experience will be considered for the Clinical Experience.

Communication:

Word limit: 1500 words maximum excluding references, tables and figures. No abstract is needed. References: 5 maximum. Figures/tables: 2 maximum. Description: Manuscripts concerning pediatric patient care will be considered for this column.

Letters to the editor

Word limit: 400 maximum excluding references, tables and figures. No abstract is needed. References: 5 maximum. Figure/table: 1 maximum. Description: Manuscripts pertaining to or not pertaining to articles published in Pediatric Investigation within the past 2 months will be considered for this column.

4. PREPARING YOUR SUBMISSION

Parts of the Manuscript

The manuscript should be submitted in separate files: title page; main text file; figures.

The main text file should be presented in the following order: (i) title, abstract and key words, (ii) main text, (iii) references, (iv) tables (each table complete with title and footnotes), (v) figure legends, (vi) appendices (if relevant). Figures and supporting information should be supplied as separate files.

The manuscript should be prepared using Times New Roman, 12, double-space, with page numbers and line numbers continuous from the title page,

Title page

The title page should contain:

(i) a short informative title that contains the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);

(ii) the full names of the authors;

(iii) the author's institutional affiliations at which the work was carried out;

(iv)a running title of less than 40 characters;

(v) The contact information of corresponding author

The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.

Authorship

Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations sectionfor details on eligibility for author listing.

Abstract

The abstract should adhere to the word count specifications under the section Manuscript Categories and Requirements. It should state the main problem, methods, results, and conclusions. It must be factual and comprehensive. The use of abbreviations and acronyms should be limited and general statements (e.g. ‘‘the significance of the results is discussed’’) should be avoided.

Keywords

Please provide three to five keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at https://www.nlm.nih.gov/mesh/.

Text

Authors should use the subheadings required for the Article Type as specified in the section 'Manuscript Categories and Requirements'.

Acknowledgments

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement

You will be asked to provide a conflict of interest statement during the submission process. See the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section for details on what to include in this section. Please ensure you liaise with all co-authors to confirm agreement with the final statement. This section should be placed after the main text and before the references.

References

We use the Chinese Medical Association system of referencing with modification, see the following for details.

All references should be numbered consecutively in order of appearance and should be as complete as possible.

In text citations should cite references in consecutive order using Arabic superscript numerals.

For cited journal articles, if there are less than six (including six) authors, all their names should be listed; if there are more than six authors, the first six authors’ names are required and followed by “et al”.

Sample references follow:

In-Text examples:

Diabetes mellitus is associated with a high risk of foot ulcers.1-3

Several interventions have been successful at increasing compliance.11,14-16

The data of Smith et al18 are further evidence of this effect.

As reported previously,1,3-6

The results were as follows4:

Journal article (1-6 authors): list all the authors.

1. King VM, Armstrong DM, Apps R. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998; 390:537-551

Journal article with more than six authors: list the first six authors followed by "et al".

2.  Newman MP, Blum S, Wong RC, Scott JG, Prain K, Wilson RJ, et al. Autoimmune encephalitis. Int Med J. 2016;46:148-157.

Journal article with no named author or group name:

3. Centers for Disease Control and Prevention (CDC). Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use--Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2010;59(9):273.

Online articles not yet published in an issue:

4.Smith JJ, Fihn SD, White RH. Treatment of allergic rhinitis. Am J Med. In press.

Book

5. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990: 1223.

Book chapter:

6. Guyton JL, Crockarell JR. Fractures of acetabulum and pelvis. In: Canale ST, ed. Campbell's Operative Orthopaedics. 10th ed. Philadelphia, PA: Mosby, Inc; 2003:2939-2984.

Electronic book:

7. Rudolph CD, Rudolph AM. Rudolph's Pediatrics. 21st ed. New York, NY: McGraw-Hill Companies; 2002.

http://online.statref.com/Document/Document.aspx?DocID=1&StartDoc=1&EndDoc=1882&FxID=13&offset=7&SessionId=A3F279FQVVFXFSXQ . Accessed August 22, 2007.

Internet document:

8. American Cancer Society. Cancer Facts & Figures 2003.

http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed March 3, 2003.

Please note that journal title abbreviations should conform to the practices of Chemical Abstracts/Medline.

Tables

Tables should be self-contained and complement, but not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Preparing Figures

Although we encourage authors to send us the highest-quality figures possible, for peer-review purposes we are happy to accept a wide variety of formats, sizes, and resolutions. The figures should be provided separately, not integrated into the text file.

Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Color figures: Figures submitted in color may be reproduced in color online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.

Appendices

Appendices will be published on line after the references. For submission they should be supplied as separate files but referred to in the text.

Supporting Information

Supporting information is information that is not essential to the article but that provides greater depth and background. It is hosted online, and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on supporting information.

Note, if data, scripts or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

General Style Points

The following links provide general advice on formatting and style.

Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units.

Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8 mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).

Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.

Spelling: The journal uses US spelling, however authors may submit using either option as spelling of accepted papers is converted during the production process.

Footnotes: Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

Wiley Author Resources

Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.

Editing, Translation and Formatting Support: Wiley Editing Services can greatly improve the chances of your manuscript being accepted. Offering expert help in English language editing, translation, manuscript formatting and figure preparation, Wiley Editing Services ensures that your manuscript is ready for submission.

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS

Editorial Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.

Wiley's policy on confidentiality of the review process is available here.

Manuscripts are assigned sequentially to Associate Editors. An Associate Editor solicits reviewers (typically, two external reviews are sought). The reviewers’ evaluations and Associate Editor’s comments are compiled by the Editor-in-Chief for disposition and transmittal to the authors.

The Editor-in-Chief will advise authors whether a manuscript is accepted, should be revised or is rejected. Minor revisions are expected to be returned within four weeks of decision; major revisions within three months. Manuscripts not revised within these time periods are subject to withdrawal from consideration for publication unless the authors can provide extenuating circumstances.

A number of manuscripts will have to be rejected on the grounds of priority and available space. A manuscript may be returned to the authors without outside review if the Editor-in-Chief and Associate Editor find it inappropriate for publication in the Journal. Similarly, the Editors may expedite the review process for manuscripts felt to be of high priority in order to reach a rapid decision. Such ‘fast-track decisions’ will normally occur within one week of receipt of the manuscript.

The Editor-in-Chief’s decision is final. If, however, authors dispute a decision and can document good reasons why a manuscript should be reconsidered, a rebuttal process exists. In the first place, authors should write to the Editor-in-Chief.

If manuscripts are submitted by an Editor, they will be assigned to and processed by other Editors to avoid conflicts of interest.

Pediatric Investigation employs a plagiarism detection system. By submitting your manuscript to this journal, you accept that your manuscript may be screened for plagiarism against previously published works.

Data Storage and Documentation

Pediatric Investigation encourages data sharing wherever possible, unless this is prevented by ethical, privacy or confidentiality matters. Authors publishing in the journal are therefore encouraged to make their data, scripts and other artefacts used to generate the analyses presented in the paper available via a publicly available data repository, however this is not mandatory. If the study includes original data, at least one author must confirm that he or she had full access to all the data in the study, and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Human Studies and Subjects

For manuscripts reporting medical studies involving human participants, we require a statement identifying the ethics committee that approved the study, and that the study conforms to recognized standards, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice.

Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher, however in signing the author license to publish authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use. The Chinese version is also available.

Animal Studies

A statement indicating that the protocol and procedures employed were ethically reviewed and approved, and the name of the body giving approval, must be included in the Methods section of the manuscript. We encourage authors to adhere to animal research reporting standards, for example the ARRIVE reporting guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines and regulations for the care and use of laboratory animals:

US authors should cite compliance with the US National Research Council's Guide for the Care and Use of Laboratory Animals, the US Public Health Service's Policy on Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory Animals.

UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).

European authors outside the UK should conform to Directive 2010/63/EU.

Clinical Trial Registration

We require that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Please include the name of the trial register and your clinical trial registration number at the end of your abstract. If your trial is not registered, or was registered retrospectively, please explain the reasons for this.

Research Reporting Guidelines

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. We encourage authors to adhere to the following research reporting standards.

Authors are encouraged to ensure their manuscript conforms to accepted best practice guidelines such as:

CONSORT guidelines for reports of randomized trials and cluster randomized trials

STROBE statement for observational studies (cohort, case–control, or cross-sectional designs)

STARD guidelines for studies of diagnostic accuracy

PRISMA guidelines for systematic reviews and meta-analyses: Complete PRISMA checklist

COREQ guidelines for qualitative studies: Complete COREQ checklist

See http://www.equator-network.org/ for other study types.

Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: http://www.crossref.org/fundingdata/registry.html

Authorship

The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:

1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;

2. Been involved in drafting the manuscript or revising it critically for important intellectual content;

3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and

4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.

Additional authorship options

Joint first or senior authorship: In the case of joint first authorship a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’

ORCID

As part of our commitment to supporting authors at every step of the publishing process, Pediatric Investigation requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information.

Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note that this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read our Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found at https://authorservices.wiley.com/ethics-guidelines/index.html

6. OPEN ACCESS LICENSE AND COPYRIGHT

Pediatric Investigation is an Open Access journal, all articles will be immediately and permanently free for everyone to read and download. To provide Open Access, this journal has an Open Access fee (also known as an article publishing charge APC) which needs to be paid by the authors or on their behalf e.g. by their research funder or institution. The APC is currently waived for this journal. Permitted third party (re)use is defined by the following Creative Commons user license.

Creative Commons Attribution Non-Commercial NoDerivatives (CC BY NC ND)

For non-commercial purposes, lets others distribute and copy the article, and include in a collective work (such as an anthology) as long as they credit the author(s) and provided they do not alter or modify the article.

Copyright

Upon acceptance of an article, authors will be asked to complete a “Copyright Transfer Form”. Acceptance of the agreement will ensure the widest possible dissemination of information. An email will be sent to the corresponding author confirming receipt of the manuscript together with a “Copyright Transfer Form” or a link to the online version of this agreement. Express written permission is required for resale or distribution of this journal and its contents, including all derivative works, compilation and/or translations. Please contact the editorial board for all inquiries (pieditorial@pediatricinvestigation.org). If experts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted article received in production

When your accepted article is received by Wiley’s production team, you (corresponding author) will receive an email asking you to login or register with Author Services. You will be asked to sign a publication license at this point.

Proofs

Once your paper is typeset you will receive an email notification of the URL from where to download a PDF typeset page proof, associated forms and full instructions on how to correct and return the file.

Please note that you are responsible for all statements made in your work, including changes made during the editorial process and thus you must check your proofs carefully. Note that proofs should be returned as soon as possible from receipt of first proof.

Early View

The journal offers rapid publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before your article appears online, as Editors also need to review proofs. Once your article is published on Early View no further changes to your article are possible. Your Early View article is fully citable and carries an online publication date and DOI for citations.

8. POST PUBLICATION

Access and sharing

When your article is published online:

You receive an email alert (if requested).

You can share a link to your published article through social media.

You can now order print copies of your article here: www.sheridan.com/wiley/eoc (instructions are sent at proofing stage).

Now is the time to start promoting your article. Find out how to do that here.

Measuring the Impact of your Work

Wiley also helps you measure the impact of your research through our specialist partnerships with Kudos and Altmetric.

9. EDITORIAL OFFICE CONTACT DETAILS

Editorial office:

56 Nanlishi Road

Beijing 100045, China

Tel: +8610-66019629

Fax: +8610-66019629

E-mail: pieditorial@pediatricinvestigation.org

Author Guidelines updated May 2019


投稿问答最小化  关闭